Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-002827
Filing Date
2013-03-15
Accepted
2013-03-15 15:05:42
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213529z10-k.htm 10-K 1187760
2 EX-10.14 a2213529zex-10_14.htm EX-10.14 160749
3 EX-10.15 a2213529zex-10_15.htm EX-10.15 153414
4 EX-10.16 a2213529zex-10_16.htm EX-10.16 177157
5 EX-10.17 a2213529zex-10_17.htm EX-10.17 156630
6 EX-10.18 a2213529zex-10_18.htm EX-10.18 162058
7 EX-10.19 a2213529zex-10_19.htm EX-10.19 156534
8 EX-21.1 a2213529zex-21_1.htm EX-21.1 149383
9 EX-23.1 a2213529zex-23_1.htm EX-23.1 3448
10 EX-31.1 a2213529zex-31_1.htm EX-31.1 7375
11 EX-31.2 a2213529zex-31_2.htm EX-31.2 7361
12 EX-32.1 a2213529zex-32_1.htm EX-32.1 4716
13 EX-32.2 a2213529zex-32_2.htm EX-32.2 4701
  Complete submission text file 0001047469-13-002827.txt   2332263
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 937-6100
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35565 | Film No.: 13693701
SIC: 2834 Pharmaceutical Preparations